Third mandate (2013-2015)
The third mandate of the HLG-MR will allow for an extension of its work in the field of security of supply of medical radioisotopes. The work will address specific issues affecting the full implementation of the HLG-MR policy approach, such as full-cost recovery and isotope reimbursement. The HLG-MR will continue to work towards increasing the long-term security of supply by maintaining transparency on global developments, communicating with the supply chain and end-users, evaluating progress towards implementation and providing additional information and analysis, where necessary. The group will meet twice a year to share information and to discuss ongoing policy issues.
The broad deliverables of the group during its third mandate are:
- Carrying out studies related to the security of supply, e.g. updating the global 99Mo/99mTc supply and demand forecast and examining waste management costs from 99Mo production.
- Evaluating progress towards the implementation of the HLG-MR policy approach through a second self-assessment by the global supply chain.
- Closer engagement with downstream supply chain participants (99mTc generator manufacturers, health policy makers and nuclear medicine professionals) to explore issues related to full-cost recovery and isotope reimbursement.
- Re-examining the six HLG-MR policy principles, in particular, those reported by market participants to be challenging to implement.
- Sharing information on the status of the 99Mo/99mTc market and regular reporting on technical developments within the market, to increase transparency and encourage consistency in approaches.
- Communicating the need to implement the HLG-MR policy approach to governments and other supply chain participants, including working more closely with health policy makers and nuclear medicine professionals.
- Actions to support the implementation of the policy approach, where appropriate and feasible.
- Regular reports to governments and other major stakeholders.
Last reviewed: 4 December 2013